Terumo : Announces Voting Results for the Election of Directors
June 27, 2017 at 04:44 am EDT
Share
June 27, 2017
Terumo Announces Voting Results for the Election of Directors
TOKYO, JAPAN - June 27, 2017 - Terumo Corporation (TSE: 4543) hereby announces the voting results for the election of directors at its Annual General Meeting of Shareholders held on June 27, 2017 in Tokyo. All candidates listed on May 10 were elected as directors of Terumo Corporation.
Directors (excluding directors who serve as Audit/Supervisory Committee Members)
Name
New position
Former position
Takayoshi Mimura
Chairman of the Board
Same as on the left
Shinjiro Sato
President and CEO
Same as on the left
Toshiaki Takagi
Director and Managing Executive Officer
Same as on the left
Shoji Hatano
Director and Managing Executive Officer
Same as on the left
Hideo Arase
Director and Senior Executive Officer
Same as on the left
David Perez
Director and Senior Executive Officer
Same as on the left
Ikuo Mori
Independent Director
Same as on the left
Ryuzo Ueda
Independent Director
Same as on the left
Directors who serve as Audit/Supervisory Committee Members
Name
New position
Former position
Yoshihiro Kimura
Director who serves as an Audit/Supervisory Committee Member
Advisor
Toshihiko Matsumiya
Independent director who serves as an Audit/Supervisory Committee Member
Same as on the left
Masatake Yone
Independent director who serves as an Audit/Supervisory Committee Member
Same as on the left
About Terumo Corporation
Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with over
$5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol , or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.
###
Terumo Corporation published this content on 27 June 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 27 June 2017 08:44:04 UTC.
Original documenthttp://www.terumo.com/about/pressrelease/2017/20170627.pdf
Public permalinkhttp://www.publicnow.com/view/C8D4E467D4C4D9B95DE00328056CF2794B449906
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).